VIXTIMOTAMAB

UNII:	56FUB33G5M
Formula:
Preferred Substance Name:	VIXTIMOTAMAB
GSRS Full Record:	56FUB33G5M i

2243775-32-6
AMV 564 [WHO-DD]
AMV564
AMV-564
CNTO 3953 TANDAB
CNTO-3953
IMMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 .KAPPA.-CHAIN VL1) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD33 ANTIGEN) (HUMAN MONOCLONAL AMV564 SINGLE-CHAIN VARIABLE FRAGMENT VH2-LINKER2-VL2) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 HEAVY CHAIN VH1)
MABFRAG HUMAN (FAB) ANTI P20138 (CD33_HUMAN)MABFRAG HUMAN (FAB) ANTI P07766 (CD3_HUMAN) (AMV564)
MMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 .KAPPA.-CHAIN VL1) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD33 ANTIGEN) (HUMAN MONOCLONAL AMV564 SINGLE-CHAIN VARIABLE FRAGMENT VH2-LINKER2-VL2) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 HEAVY CHAIN VH1)
T652
T-652
VIXTIMOTAMAB [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VIXTIMOTAMAB

Synonyms and Mappings

Resources